“EOS continues to produce and deliver against this contract and anticipates further cash receipts of over $100 million from this business in H2 2021.”
So, where is the medium term risk of a capital raise? Isn’t speculation of a raise the reason behind the large short position?
And as a reminder:
“The growth outlook for the company is exceptionally strong as it is facing what Dr Greene described as a “demand tsunami on the horizon”.”
And guidance reiterated:
-Order backlog of executed orders at 27 May was $428 million in revenue terms, and $535 million in cash flow.
-Cash receipts are expected to be strong as contract assets convert to cash, in a reversal of 2020 cash deployment.
Cheers
